Projects
A Phase 2a, Double Blind, Randomized, Placebo-controlled, 28 day, Two-arm, Parallel Group Study of A0001 in Patients with the A3243G Mitochondrial DNA Point Mutation and Evidence of Impaired Mitochondrial Function
- Project Leader: Professor Patrick Chinnery
- Sponsors: Penwest Pharmaceuticals
Staff Profile: Professor Patrick Chinnery